EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Differential Impacts of Endogenous Antioxidants on Clinical Symptoms and Cognitive Function in Acute and Chronic Schizophrenia Patients

Chieh-Hsin Lin iD, Tin-May Li, Yu-Jhen Huang, Shaw-Ji Chen, Hsien-Yuan Lane

International Journal of Neuropsychopharmacology · 29.08.2023 · 26 (8) · 576-583

DOI: 10.1093/ijnp/pyad040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 09.07.2023. Verfasst von Chieh-Hsin Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health Research Institutes, Ministry of Science and Technology, Taiwan, Chang Gung Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Impaired antioxidant defense is implicated in the pathophysiology of schizophrenia, and superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) are 3 first-line endogenous antioxidants. Various cognitive functions decline differently during the schizophrenia course. The characteristic roles of the 3 antioxidants in clinical and cognitive profiles in acute and chronic phases of schizophrenia require study.

Methods

We recruited 311 patients with schizophrenia, including 92 acutely exacerbated patients who had been off antipsychotics for at least 2 weeks and 219 chronic patients who had been stable on medication for at least 2 months. Blood SOD, CAT, and GSH levels; clinical symptoms; and 9 cognitive test scores were measured.

Results

Blood CAT levels were higher in the acute patients than in the chronic patients, whereas SOD and GSH levels were similar to one another. Higher CAT levels were correlated with less positive symptoms, better working memory and problem solving in the acute phase, and less negative symptoms, less general psychopathology, better global assessment of function, and better cognitive function (in speed of processing, attention, problem solving) in the chronic period. Higher SOD levels were correlated with better global assessment of function in the acute phase and better speed of processing, working memory, and verbal learning and memory in the chronic period. GSH influenced neither clinical nor cognitive manifestations.

Conclusions

This study showed that blood CAT affected different clinical and cognitive domains between acute and chronic stages of schizophrenia, SOD influenced cognitive functions in chronic state, but GSH affected none. Further studies are needed to explore the underlying mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaAntipsychotic AgentsHumansAntioxidantsCognitionGlutathioneSuperoxide DismutaseGlutathione Peroxidase

Stichwörter der Autor:innen

Antioxidantscognitive functionsnegative symptomspositive symptomsschizophrenia

Substanzen

AntioxidantsAntipsychotic AgentsGlutathioneSuperoxide DismutaseGlutathione Peroxidase

Autor:innen und Institutionen

  • Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • School of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
  • Department of Psychiatry and Center for Addiction and Mental Health, China Medical University Hospital, Taichung, Taiwan.
  • Department of Psychiatry, Mackay Memorial Hospital Taitung Branch, Taitung, Taiwan.
  • Department of Medicine, Mackay Medical College, New Taipei, Taiwan.

ORCID-Profile: Chieh-Hsin Lin

Förderung

  • National Health Research Institutes
  • Ministry of Science and Technology, Taiwan
  • Chang Gung Memorial Hospital
  • China Medical University Hospital

Zitieren

APA

Lin, C. H., Li, T. M., Huang, Y. J., Chen, S. J., & Lane, H. Y. (2023). Differential Impacts of Endogenous Antioxidants on Clinical Symptoms and Cognitive Function in Acute and Chronic Schizophrenia Patients. International Journal of Neuropsychopharmacology, 26(8), 576-583. https://doi.org/10.1093/ijnp/pyad040

Vancouver

Lin CH, Li TM, Huang YJ, Chen SJ, Lane HY. Differential Impacts of Endogenous Antioxidants on Clinical Symptoms and Cognitive Function in Acute and Chronic Schizophrenia Patients. International Journal of Neuropsychopharmacology. 2023;26(8):576-583. doi:10.1093/ijnp/pyad040

BibTeX
@article{Lin2023,
  author = {Lin, Chieh-Hsin and Li, Tin-May and Huang, Yu-Jhen and Chen, Shaw-Ji and Lane, Hsien-Yuan},
  title = {Differential Impacts of Endogenous Antioxidants on Clinical Symptoms and Cognitive Function in Acute and Chronic Schizophrenia Patients},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2023},
  volume = {26},
  number = {8},
  pages = {576--583},
  doi = {10.1093/ijnp/pyad040}
}
Kostenlos starten →